| CAS No. | 1330782-76-7 |
|---|---|
| MDL No. | N/A |
| MF | C17H19N5OS |
| MW | 341.40 |
| InChI Key | XGVXKJKTISMIOW-ZDUSSCGKSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 2 mg | 99% | $64 | In Stock | |
| 5 mg | 99% | $107 | In Stock | |
| 10 mg | 99% | $174 | In Stock | |
| 25 mg | 99% | $295 | In Stock | |
| 50 mg | 99% | $469 | In Stock | |
| 100 mg | 99% | $749 | In Stock | |
| 250 mg | 99% | $1272 | In Stock | |
| 1 g | 99% | $4062 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Simurosertib is an orally bioavailable inhibitor of CDC7 (cell division cycle 7-related protein kinase), with potential antineoplastic activity. It binds to and inhibits CDC7, preventing DNA replication initiation during mitosis, leading to cell cycle arrest and apoptosis, thereby inhibiting growth in CDC7-overexpressing tumor cells.
| CAS No. | 1330782-76-7 |
|---|---|
| Product Name | Simurosertib |
